A radiogenomics signature for predicting the clinical outcome of bladder urothelial carcinoma

European Radiology Dec 06, 2019

Lin P, Wen D, Chen L, et al. - RNA sequencing data, radiomics peculiarities, and clinical parameters of 62 individuals with bladder urothelial carcinoma (BLCA) were analyzed in this study to determine the integrative value of contrast-enhanced CT (CECT), transcriptomics data, and clinicopathological data for prognosticating the survival of those with BLCA. In people with BLCA, progression-free interval prognostication was enhanced by integrative nomogram, which included CECT radiomics, transcriptomics, and clinical characteristics, and this was found to be a feasible and practical source for oncological precision medicine.

Go to Original

Sign-up to continue reading. It is free & takes less than 2 mins

  • 45 lakhs+ doctors trust M3 globally

  • Nonloggedininfinity icon
    Free & unlimited access to original articles and quizzes
  • Nonloggedinlock icon
    Secure: we never sell your data
This article is only available to members. Are you a doctor? Click here to signup for free.
Try M3 India / Log In
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen